These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21545499)

  • 21. Antibacterial activity of Thai herbal extracts on acne involved microorganism.
    Niyomkam P; Kaewbumrung S; Kaewnpparat S; Panichayupakaranant P
    Pharm Biol; 2010 Apr; 48(4):375-80. PubMed ID: 20645714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem.
    Hayashi N; Kawashima M
    J Dermatol; 2011 Feb; 38(2):111-9. PubMed ID: 21269305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetracycline-resistant staphylococci in acne vulgaris.
    Shalita AR; Rosenthal SA
    Acta Derm Venereol; 1972; 52(1):64-6. PubMed ID: 4111110
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment.
    Borelli C; Merk K; Schaller M; Jacob K; Vogeser M; Weindl G; Berger U; Plewig G
    Acta Derm Venereol; 2006; 86(4):316-9. PubMed ID: 16874416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts in therapy: the treatment of acne with antibiotics.
    South Med J; 1973 Apr; 66(4):494-6. PubMed ID: 4267707
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
    Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
    Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral treatment of acne. Agence Française de Securité Sanitaire des Produits de Santé].
    Presse Med; 1999 Nov; 28(37):2044-5. PubMed ID: 10605476
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
    Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
    J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Propionibacterium acnes in acne vulgaris (comparative biochemical study of the comedone and the pustule].
    Laso JL; Gutiérrez de da Costa G; Vignale RA; Assandri J
    Med Cutan Ibero Lat Am; 1980; 8(1-3):47-51. PubMed ID: 6455573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of macrolide therapy on patients with acne vulgaris].
    Akamatsu H
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():109-12. PubMed ID: 11439886
    [No Abstract]   [Full Text] [Related]  

  • 36. Newer approaches in topical combination therapy for acne.
    Fu LW; Vender RB
    Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
    Leyden JJ; Del Rosso JQ; Webster GF
    Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.